Clinical Study of Tamsulosin Combined with Escitalopram in the Treatment of Chronic Abacterial Prostatitis with Anxiety and Depression

ZHANG Hongliang; LIU Qianqian; YANG Dayu; SUN Jingcun

doi:10.14009/j.issn.1672-2124.2022.03.016

您当前的位置：

首页 >

文章列表页 >

Clinical Study of Tamsulosin Combined with Escitalopram in the Treatment of Chronic Abacterial Prostatitis with Anxiety and Depression

更新时间：2022-10-08

- Clinical Study of Tamsulosin Combined with Escitalopram in the Treatment of Chronic Abacterial Prostatitis with Anxiety and Depression
- Vol. 22, Issue 3, Pages: 323-326(2022)
- 作者机构：
  
  1. 河北省沧州中西医结合医院泌尿外科
  2. 河北省沧州中西医结合医院重症医学科
  3. 河北省沧州中西医结合医院西药学部
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2022.03.016
  CLC： R697.33
- Published：2022，
扫描看全文
ZHANG Hongliang, LIU Qianqian, YANG Dayu, et al. Clinical Study of Tamsulosin Combined with Escitalopram in the Treatment of Chronic Abacterial Prostatitis with Anxiety and Depression. [J]. 22(3):323-326(2022)
DOI：

ZHANG Hongliang, LIU Qianqian, YANG Dayu, et al. Clinical Study of Tamsulosin Combined with Escitalopram in the Treatment of Chronic Abacterial Prostatitis with Anxiety and Depression. [J]. 22(3):323-326(2022) DOI： 10.14009/j.issn.1672-2124.2022.03.016.

摘要

目的：探讨坦索罗辛联合艾司西酞普兰治疗慢性非细菌性前列腺炎伴焦虑抑郁的临床效果。方法：纳入2015—2019年该院收治的200例慢性非细菌性前列腺炎伴焦虑抑郁患者，根据治疗方案的不同，分为对照组与联合组，每组100例。对照组患者采用坦索罗辛联合安慰剂进行治疗，联合组患者采用坦索罗辛联合艾司西酞普兰进行治疗。比较两组患者美国国立卫生研究院-慢性前列腺炎症状指数(NIH-CPSI)量表评分、白细胞计数、卵磷脂小体数量、最大尿流率、平均尿流率、汉密尔顿抑郁量表(HAMD)评分、生活质量综合评定问卷评分和不良反应发生情况的差异。结果：对照组患者的治疗总有效率为80%(80/100)

联合组患者的治疗总有效率为100%

两组的差异有统计学意义(P<0.000 1)。治疗后，与对照组比较，联合组患者白细胞计数、NIH-CPSI评分的降低幅度更为明显，差异有统计学意义(P<0.01)

且联合组患者的卵磷脂小体数量增多，最大尿流率、平均尿流率升高。治疗后，联合组患者的HAMD评分明显低于对照组，生活质量综合评定问卷(包括躯体疼痛、生理功能、情感职能、精神状态和社会功能)评分明显高于对照组，差异均有统计学意义(P<0.05)。联合组患者头痛、嗜睡和头晕不良反应的发生率明显低于对照组，差异均有统计学意义(P<0.05)。结论：坦索罗辛联合艾司西酞普兰能够显著提高慢性非细菌性前列腺炎伴焦虑抑郁患者的临床治疗效果，安全可靠。

Abstract

OBJECTIVE: To probe into the clinical effects of tamsulosin combined with escitalopram in the treatment of chronic abacterial prostatitis with anxiety and depression. METHODS: Totally 200 patients with chronic abacterial prostatitis with anxiety and depression admitted into this hospital from 2015 to 2019 were extracted to be divided into the control group and the combined group according to different treatment regimens

with 100 cases in each group. The control group was treated with tamsulosin combined with placebo

while the combined group received tamsulosin combined with escitalopram. National Institutes of Health-Chronic Prostatitis Symptom Index（NIH-CPSI）

white blood cell count

lecithin body count

maximum urine flow rate

mean urine flow rate

Hamilton Depression Scale（HAMD） score

score of questionnaire for comprehensive assessment of quality of life and adverse drug reactions of two groups were compared. RESULTS: The total effective rate was 80%（80/100） in the control group and 100% in the combined group

and the difference was statistically significant（P<0.000 1）. After treatment

compared with the control group

the white blood cell count and NIH-CPSI score decreased more significantly in the combined group

with statistically significant differences（P<0.01）; the lecithin body count of the combined group increased

the maximum urine flow rate and mean urine flow rate also increased. After treatment

the HAMD score of the combined group was significantly lower than that of the control group

and the scores of questionnaire for comprehensive assessment of quality of life（including physical pain

physical function

emotional function

mental state and social function） were significantly higher than that of the control group

with statistically significant differences（P<0.05）. The incidences of headache

sleepiness and dizziness in the combined group were significantly lower than those in the control group

with statistically significant differences（P<0.05）. CONCLUSIONS: Tamsulosin combined with escitalopram can significantly improve the clinical efficacy of chronic abacterial prostatitis with anxiety and depression

which is safe and reliable.

关键词

坦索罗辛艾司西酞普兰慢性非细菌性前列腺炎焦虑抑郁临床疗效

Keywords

TamsulosinEscitalopramChronic abacterial prostatitisAnxiety and depressionClinical efficacy

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Huanshao Capsules Combined with Tamsulosin Hydrochloride in the Treatment of Premature Ejaculation of Spleen and Kidney Yang Deficiency Type

Effects of Fiberoptic Bronchoalveolar Lavage Combined with Azithromycin on Immune Function, Serum MCP-4, MAPK and CysLTR1 in Children with Mycoplasma Pneumoniae Pneumonia

Clinical Efficacy and Safety of Osimertinib in the Treatment of EGFR Gene Mutation-Positive NSCLC Patients in the Real World

Placental Permeability of Escitalopram Based on Human Placental Extracorporeal Circulation Perfusion Model

Effects of Doxepin Combined with Escitalopram on Levels of Glial Cell-Derived Neurotrophic Factor and 5-Hydroxytryptamine in Patients with Depression

Related Author

DOU Jianguo

JIANG Daobin

QIU Ming

GAO Yu

ZHANG Juan

ZHAO Dongmei

TAN Qiong

SUN Yi

Related Institution

Dept. of Urology, Dazu District People’s Hospital

Pediatric Intensive Care Unit, Chengdu Women’s and Children’s Central Hospital

Dept. of Pediatrics, Nanchong Central Hospital

College of Pharmacy, Dali University

Dept.of Pharmacy, the First People’s Hospital of Yunnan/Kunhua Hospital Affiliated to Kunming University of Science and Technology

⁰